May 9 -- Here are some of the latest health and medical news developments, compiled by editors of HealthDay: Pull Ortho-Evra Birth-Control Patch From Market: Public Citizen The Ortho-Evra birth ...
It’s should be common knowledge that the Johnson & Johnson (J&J) Ortho-Evra birth-control patch has more risks than the birth control pill (it’s on the label) — because it exposes women to higher ...
FORT WORTH, Texas, Sept. 21 /PRNewswire/ -- The U.S. Food and Drug Administration's announcement that additional warnings have been added to the label for Johnson & Johnson's (NYSE: JNJ) Ortho Evra ...
FORT WORTH, Texas, Nov. 28 /PRNewswire/ -- The maker of the Evra* birth control patch sold in Canada is warning women there that they are at "particularly high risk" of developing blood clots if they ...
The patch supplies norelgestromin and ethinyl estradiol to the bloodstream through the skin. Has any evidence of genital swelling been documented with the use of the patch when placed inappropriately?
The makers of a popular birth-control patch warned millions of women Thursday that the patch exposes them to significantly higher doses of hormones and may put them at greater risk for blood clots and ...
Johnson & Johnson misled doctors and regulators for years by altering and withholding medical data about the health risks of its Ortho Evra birth-control patch, lawyers for women suing the company ...
For years, Johnson & Johnson obscured evidence that its popular Ortho Evra birth-control patch delivered much more estrogen than standard birth-control pills, potentially increasing the risk of blood ...
WASHINGTON - Risks of blood clots in legs and lungs are twice as high for women using the birth control patch instead of the pill, says a study reported by the drug maker and the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results